-
1دورية أكاديمية
المؤلفون: Ling-Yun Zhou, Shuo-Fei Yang, Zhen Zhang, Chi Zhang, Long Shen, Zhi-Chun Gu, Xiao-Cong Zuo
المصدر: Frontiers in Physiology, Vol 9 (2018)
مصطلحات موضوعية: renal function, nonvalvular atrial fibrillation, non-vitamin K antagonist oral anticoagulants, trade-off analysis, dabigatran, rivaroxaban, Physiology, QP1-981
العلاقة: https://www.frontiersin.org/article/10.3389/fphys.2018.01644/fullTest; https://doaj.org/toc/1664-042XTest; https://doaj.org/article/3df47a115b1b46b091ac94da7e410262Test
الإتاحة: https://doi.org/10.3389/fphys.2018.01644Test
https://doaj.org/article/3df47a115b1b46b091ac94da7e410262Test -
2دورية أكاديمية
المؤلفون: Zhi-Chun Gu, Ling-Yun Zhou, Long Shen, Chi Zhang, Jun Pu, Hou-Wen Lin, Xiao-Yan Liu
المصدر: Frontiers in Pharmacology, Vol 9 (2018)
مصطلحات موضوعية: non-vitamin K antagonist oral anticoagulants, warfarin, fractures, bone, meta-analysis, risk factors, Therapeutics. Pharmacology, RM1-950
العلاقة: http://journal.frontiersin.org/article/10.3389/fphar.2018.00348/fullTest; https://doaj.org/toc/1663-9812Test; https://doaj.org/article/c8b995fa877b4b7893852d596cde0c70Test
الإتاحة: https://doi.org/10.3389/fphar.2018.00348Test
https://doaj.org/article/c8b995fa877b4b7893852d596cde0c70Test -
3
المؤلفون: Xiao-Cong Zuo, Zhi-Chun Gu, Ling-Yun Zhou, Zhen Zhang, Chi Zhang, Shuo-Fei Yang, Long Shen
المصدر: Frontiers in Physiology
Frontiers in Physiology, Vol 9 (2018)مصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, Physiology, non-vitamin K antagonist oral anticoagulants, apixaban, Renal function, 030204 cardiovascular system & hematology, lcsh:Physiology, law.invention, Dabigatran, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Edoxaban, Physiology (medical), Internal medicine, medicine, dabigatran, 030212 general & internal medicine, trade-off analysis, rivaroxaban, Rivaroxaban, lcsh:QP1-981, business.industry, renal function, Warfarin, nonvalvular atrial fibrillation, Vitamin K antagonist, chemistry, edoxaban, Apixaban, Systematic Review, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::470d6b4f369c261ebbf1838208472e5cTest
http://europepmc.org/articles/PMC6256743Test -
4
المؤلفون: Xiao-Yan Liu, Zhi-Chun Gu, Long Shen, Chi Zhang, Ling-Yun Zhou, Hou-Wen Lin, Jun Pu
المصدر: Frontiers in Pharmacology, Vol 9 (2018)
Frontiers in Pharmacologyمصطلحات موضوعية: medicine.medical_specialty, medicine.drug_class, non-vitamin K antagonist oral anticoagulants, Subgroup analysis, 030204 cardiovascular system & hematology, Lower risk, bone, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Medicine, risk factors, Pharmacology (medical), 030212 general & internal medicine, Pharmacology, business.industry, lcsh:RM1-950, Absolute risk reduction, Warfarin, Vitamin K antagonist, fractures, warfarin, meta-analysis, lcsh:Therapeutics. Pharmacology, Relative risk, Meta-analysis, Systematic Review, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48eac23384d9480e73e514d4ca3ebea8Test
http://journal.frontiersin.org/article/10.3389/fphar.2018.00348/fullTest